The University of Chicago Header Logo

Connection

Derek Wainwright to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Derek Wainwright has written about Xenograft Model Antitumor Assays.
Derek Wainwright
Connection Strength
0.366
Xenograft Model Antitumor Assays
  1. IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma. Clin Cancer Res. 2018 06 01; 24(11):2559-2573.
    View in: PubMed
    Score: 0.133
  2. Therapeutic Hypothesis Testing With Rodent Brain Tumor Models. Neurotherapeutics. 2017 04; 14(2):385-392.
    View in: PubMed
    Score: 0.125
  3. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.
    View in: PubMed
    Score: 0.043
  4. A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 2018 10; 15(4):1127-1138.
    View in: PubMed
    Score: 0.035
  5. Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival. Clin Cancer Res. 2017 Nov 01; 23(21):6650-6660.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.